View Older Stories View More Recent Stories
-
Roth Capital Trims PT on Energy Focus (EFOI) to $5 Following Q2 Results
-
Roth Remains Positive on BioLineRx (BLRX) Following Q2 Report, CEO Succession
-
Roth Capital Downgrades Marchex (MCHX) to Neutral
-
Radisys to Participate at Upcoming Financial Conferences
-
Roth Capital Upgrades Clayton Williams Energy (CWEI) to Neutral
-
Fibrocell Announces Proposed Public Offering of Common Stock and Warrants
-
TG Therapeutics (TGTX) Seen Firing on All Cylinders Post-Q2 Results; Roth Affirms at 'Buy'
-
Vista Gold Corp. Completes Previously Announced US$17.3 Million Bought Deal Offering of Units
-
Roth Capital Upgrades Diamondback Energy (FANG) to Buy
-
Check-Cap Ltd. Announces $5.9 Million Financing
-
Roth Affirms Manitex (MNTX) at 'Buy'; Cost Improvement Initiatives Shine in Q2
-
Streetinsider.com's Hot Lunchtime Reads 8/5: (MU) (MRK) (LGND) (FIVE)
-
Roth Capital Says to Buy Ligand Pharma (LGND) on Today's 'Bad' Downgrade
-
Notable Analyst Rating Changes 8/5: (SYMC) (COH) (OAS) Upgraded; (ICPT) (PKI) (REGN) Downgraded
-
Capstone Turbine (CPST) Moves Past Transitional Year; Pipeline Remains Robust - Roth Capital
-
Roth Capital Downgrades Super Micro Computer (SMCI) to Neutral
-
Roth Capital Downgrades ReneSola Ltd. (SOL) to Sell
-
Roth Capital Resumes Pieris Pharmaceuticals (PIRS) at Buy
-
Roth Capital Downgrades JinkoSolar Holding Co., Ltd. (JKS) to Neutral
-
Canadian Solar (CSIQ) Better-Positioned vs. Peers Amid Expected Solar Glut - Roth Capital
-
Palatin Technologies Announces Closing of $9.2 Million Financing
-
Roth Keeps Regeneron (REGN) at 'Buy' Following Q2 Report; Says 'Blocking and Tackling' Continues
-
Roth Capital Bumps PT on Ligand Pharma (LGND) up to $149; Says Running on All Cylinders
-
Streetinsider.com's Hot Lunchtime Reads 8/4: (P) (QTWO) (JACK) (FSLR)
-
Roth Capital Sees FY17 Ests on First Solar (FSLR) Turning Lower; Trims PT to $55
-
Ellie Mae, Inc. Announces Pricing of Follow-on Offering of Common Stock
-
Roth Capital Upgrades Etsy (ETSY) to Neutral
-
ROTH Capital Partners Expands Technology with Addition of Suji Desilva, CFA as a Senior Research Analyst In Technology
-
Roth Capital Downgrades SodaStream International (SODA) to Neutral
-
Palatin Technologies Announces $9.25 Million Financing
-
Ellie Mae, Inc. Announces Launch of Follow-on Offering
-
Roth Capital Mulls Trajectory for Trina Solar (TSL) Amid Merger Deal; Affirms at 'Neutral'
-
Roth Affirms SolarCity (SCTY) at 'Neutral'; $150M of Cost Synergies in Tesla (TSLA) Deal Expected
-
Notable Analyst Rating Changes 7/28: (ABCO) (AXTI) (BLDP) Upgraded; (DNKN) (ASH) (TERP) Downgraded
-
Argos Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock and Warrants
-
Roth Capital Resumes Stamps.com (STMP) at Buy
-
Cytokineti cs(CYTK) Notches New Milestone with Expanded Astellas Partnership - Roth Capital
-
Ocean Power Tech (OPTT) Closes 'Best Efforts' Common Stock, Warrants Offering for Net Proceeds of $3.6M
-
Ocean Power Technologies Announces Closing of Best Efforts Public Offering of Common Stock and Warrants
-
Roth Affirms Ballard Power (BLDP) at 'Buy'; Expects Inline Q2; Growth Trajectory Continues Firming
-
Roth Capital Trims PT on GenVec (GNVC) to $2 Following CGF166 Clinical Hold Lift
-
LiquidSpace Partners with Premier Business Centers®
-
Roth Capital Downgrades Outerwall Inc. (OUTR) to Sell
-
Ocean Power Technologies (OPTT) Prices 595K Units at $6.75 Each
-
Ocean Power Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
-
Electrovaya Joins the OTCQX Market in the United States
-
OTC Markets Group Welcomes Electrovaya to OTCQX
-
Ocean Power Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Ocean Power Technologies (OPTT) to Offer Common Stock and Warrants
-
xG Technology, Inc. Announces Closing of Public Underwritten Offering
